Scarica l'app Stockscreener
24.28
0.08%
-0.02
Dopo l'orario di chiusura:
23.98
-0.30
-1.24%
Precedente Chiudi:
$24.30
Aprire:
$24.18
Volume 24 ore:
14,962
Relative Volume:
1.89
Capitalizzazione di mercato:
$N/A
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+0.08%
1M Prestazione:
-2.29%
6M Prestazione:
-12.73%
1 anno Prestazione:
-9.16%
Intervallo 1D:
$23.43
$24.28
Intervallo di 1 settimana:
$23.43
$24.44
Portata 52W:
$20.10
$30.11
Tema Oncology Etf Stock (CANC) Company Profile
Nome
Tema Oncology Etf
Settore
Industria
Telefono
-
Indirizzo
-
Confronta CANC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CANC
Tema Oncology Etf
|
24.28 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
289.88 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
589.39 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
592.15 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
228.19 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
519.11 | 124.43B | 0 | 0 | 0 | 0.00 |
Tema Oncology Etf Borsa (CANC) Ultime notizie
How to Take Advantage of moves in (CANC) - news.stocktradersdaily.com
5 Small-cap Biotech ETFs to Watch - Investing News Network
Learn to Evaluate (CANC) using the Charts - news.stocktradersdaily.com
(CANC) Technical Pivots with Risk Controls - news.stocktradersdaily.com
(CANC) Investment Analysis and Advice - news.stocktradersdaily.com
(CANC) Technical Data - news.stocktradersdaily.com
Trend Tracker for (CANC) - Stock Traders Daily
How To Trade (CANC) - Stock Traders Daily
7 Best-Performing Biotech ETFs for March 2025 - NerdWallet
When (CANC) Moves Investors should Listen - Stock Traders Daily
Psychedelic ETF PSIL Is 2025's Best-Performing ETF - etf.com
(CANC) Long Term Investment Analysis - Stock Traders Daily
(CANC) Trading Report - Stock Traders Daily
Tema Oncology ETF (NASDAQ:CANC) Short Interest Update - Defense World
Trading (CANC) With Integrated Risk Controls - Stock Traders Daily
Tema Oncology ETF (NASDAQ:CANC) Shares Sold by Jane Street Group LLC - Defense World
Reshoring ETF Gets Boost From Trump Trade - etf.com
Long Term Trading Analysis for (CANC) - Stock Traders Daily
Tema's New VOLT ETF Sparked by AI Revolution - etf.com
Disruptive Theme of the Week: Breakthroughs in Medicine - ETF Trends
(CANC) Investment Analysis - Stock Traders Daily
5 Small-cap Biotech ETFs to Watch (Updated 2024) - Nasdaq
Tema American Reshoring ETF: Benefiting From The Return Of U.S. Manufacturing - Seeking Alpha
Tema ETFs CIO on the Power of Biotech as a Source of Return Yuri Khodjamirian on Opportunities to Invest in Biotech - Opto RoW
9 Best Biotech ETFs for 2024 - MSN
How Big Pharma Is Taking A Page Out Of Novartis' Playbook - Investor's Business Daily
10 Best Performing Biotech ETFs in 2024 - Yahoo Finance
The 5 Best Biotech ETFs of 2024 - etf.com
11 Best Biotech ETFs To Buy - Yahoo Finance
Viking Therapeutics' weight-loss tablet shows promise in small study - ETHealthWorld
Tema ETFs: A Better Way to Invest in Life Sciences - StreetInsider
Tema ETFs hops on weight-loss drug frenzy with its new cardiovascular fund - Reuters
12 Best Healthcare ETFs To Buy - Yahoo Finance
Investing in Oncology: A Biotech Revolution in Research, Diagnosis, and Treatment of Cancer - Nasdaq
Inside Tema ETFs' New Oncology ETF (CANC) - Nasdaq
Royalties and cancer treatments: Thematic ETFs take new directions - Investment News
Thematic ETFs Struggle to Capture Financial Advisors’ Attention - ETF.com
Tema launches three innovative, professionally managed thematic ETFs: American Reshoring, Luxury, & Monopolies and Oligopolies - Business Wire
Getting in on global luxury - ETF Strategy
Biotechnology ETF List - ETFdb.com
Tema Oncology Etf Azioni (CANC) Dati Finanziari
Non sono disponibili dati finanziari per Tema Oncology Etf (CANC). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.16%
0.09%
Capitalizzazione:
|
Volume (24 ore):